勛圖惇蹋 AI delivers industry-specific AI for the next chapter in life sciences<\/i><\/p>\n
\nPLEASANTON, CA \u2014 3 Dec. 2025 \u2014<\/strong> In a major milestone for 勛圖惇蹋 AI<\/a>, industry-specific AI for life sciences, 勛圖惇蹋 Systems<\/a> (NYSE: VEEV) today announced the availability of 勛圖惇蹋 AI Agents for Vault CRM<\/a> and PromoMats<\/a>. 勛圖惇蹋 AI in the 勛圖惇蹋 Vault Platform and deep, specialized AI agents working in 勛圖惇蹋 applications deliver practical AI with clear business value. Additional 勛圖惇蹋 AI Agents for clinical, regulatory, safety, quality, medical, and commercial are planned for release throughout 2026.<\/p>\n \n\u201cWith industry-specific 勛圖惇蹋 AI Agents working seamlessly in 勛圖惇蹋 applications, the life sciences industry can increase productivity, customer centricity, and advance to new ways of working,\u201d said Andy Han, senior vice president, 勛圖惇蹋 AI. \u201cThanks to our customers for your collaboration as we rapidly develop practical AI that can have a significant impact on the industry.\u201d<\/p>\n 勛圖惇蹋 AI Now Available for Vault CRM<\/strong><\/p>\n 勛圖惇蹋 AI Now Available for PromoMats<\/strong><\/p>\n \n勛圖惇蹋 AI Agents work seamlessly within 勛圖惇蹋 applications and have direct, secure access to data, documents, and workflows and operate within established user access controls, permissions, and audit trails. Customers can also configure and extend 勛圖惇蹋-delivered AI Agents and build their own custom agents with 勛圖惇蹋 AI.\n<\/p>\n \n勛圖惇蹋 Business Consulting provides support for the business process design and change management necessary as companies define new business and process flows among users and agents.\n<\/p>\n \nFor the latest 勛圖惇蹋 AI information, customers can visit the 勛圖惇蹋 AI Community on 勛圖惇蹋 Connect<\/a> and join tomorrow\u2019s Q&A to learn more about 勛圖惇蹋 AI in Vault CRM<\/a>.\n<\/p>\n \nWhat the Industry is Saying About 勛圖惇蹋 AI<\/strong><\/p>\n \n\u201cBy embedding AI into every step of the customer journey \u2014 from how practitioners receive valuable information about our portfolio to how they engage with our field force \u2014 勛圖惇蹋 AI is ideally positioned to support us in our mission to deliver life-changing medicines to patients worldwide.\u201d<\/p>\n \n\u201cWhat we\u2019ve learned as an early access user is that the 勛圖惇蹋 AI Quick Check Agent moves Moderna closer to a process where parts of MLR could become nearly touch-free. That\u2019s the vision \u2014 and now we can genuinely see how we might get there.\u201d<\/p>\n \n\u201cVault CRM and 勛圖惇蹋 AI Agents like Pre-call Agent and Voice Agent will drive efficiencies and allow the field to focus on the value parts of their jobs. It\u2019s good for the business, good for HCPs, and great for patients.\u201d<\/p>\n \n\u201c勛圖惇蹋 is a critical system on our transformation roadmap, and it always has been. Being able to share the innovation with the leadership team and to introduce 勛圖惇蹋 AI embedded into our 勛圖惇蹋 applications is important to us as we expand our partnership.\u201d<\/p>\n \n\u201cWe\u2019re excited to use the 勛圖惇蹋 AI Free Text Agent as part of our strategy toward building AI capabilities into our business. 勛圖惇蹋 AI enables us to gain deeper customer insights for more effective engagement in the rare disease space.\u201d<\/p>\n \n\u201cAccenture was an early 勛圖惇蹋 AI Partner because we believe that 勛圖惇蹋\u2019s unique industry-specific approach to AI will meaningfully increase productivity in life sciences. With our deep expertise in life sciences and proven ability to scale AI, we look forward to working together to ensure customers gain practical value from 勛圖惇蹋 AI.\u201d<\/p>\n \n\u201cWe expect 勛圖惇蹋 AI Agents like Free Text Agent and Voice Agent will drive efficiency gains and insight capture that can have a transformative impact on how commercial teams operate into the future. EY is excited to support organizations on this journey toward next generation customer engagement.\u201d<\/p>\n \nAbout 勛圖惇蹋 Systems<\/strong> 勛圖惇蹋 Forward-Looking Statements<\/strong> ###<\/center><\/p>\n\n
\n
\nBristol Myers Squibb<\/div>\n<\/p>\n
\nModerna<\/div>\n<\/p>\n
\nNovo Nordisk<\/div>\n<\/p>\n
\nOtsuka Europe<\/div>\n<\/p>\n
\nCrinetics<\/div>\n<\/p>\n
\nAccenture<\/div>\n<\/p>\n
\nErnst & Young AG<\/div>\n<\/p>\n
\n勛圖惇蹋 delivers the industry cloud for life sciences with software, data, and business consulting. Committed to innovation, product excellence, and customer success, 勛圖惇蹋 serves more than 1,500 customers, ranging from the world\u2019s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation<\/a>, 勛圖惇蹋 is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com\/eu<\/a>.\n<\/p>\n
\nThis release contains forward-looking statements regarding 勛圖惇蹋\u2019s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended October 31, 2025, which you can find here<\/a> (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov<\/a>.\n<\/p>\n